Home> Products> lipid lowering medication for cholesterol

{ "products": [ { "_id": "6815f503b631af66ff8479d0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ATOVASTRIN EZ F", "description": "ATOVASTRIN EZ F is a scientifically formulated triple-action lipid-lowering medication designed for the comprehensive management of dyslipidemia and mixed hyperlipidemia. Combining Atorvastatin, Fenofibrate, and Ezetimibe, this powerful therapy targets multiple pathways of cholesterol and triglyceride metabolism. It is ideal for patients with elevated LDL cholesterol, triglycerides, and low HDL levels, helping reduce cardiovascular risk effectively.\n\nKey Ingredients\nAtorvastatin Calcium (10 mg):\nA statin that inhibits HMG-CoA reductase, reducing cholesterol production in the liver and lowering LDL (bad cholesterol) and total cholesterol levels.\n\nFenofibrate (160 mg):\nA fibrate that activates peroxisome proliferator-activated receptors (PPAR-alpha) to enhance the breakdown of triglycerides and increase HDL (good cholesterol) levels.\n\nEzetimibe IP (10 mg):\nA cholesterol absorption inhibitor that works at the intestinal level to block the absorption of cholesterol from food, further lowering blood cholesterol.\n\nKey Benefits\nComprehensive control of LDL, HDL, and triglyceride levels\n\nReduces total cholesterol and prevents the buildup of arterial plaque\n\nImproves cardiovascular outcomes in patients at high risk\n\nTargets cholesterol absorption, production, and clearance simultaneously\n\nBeneficial for patients with mixed dyslipidemia, metabolic syndrome, or diabetic dyslipidemia\n\nSupports long-term heart and blood vessel health\n\nHow Does It Work?\nATOVASTRIN EZ F works through a three-pronged mechanism to lower lipid levels:\n\nAtorvastatin blocks HMG-CoA reductase in the liver, reducing cholesterol synthesis and increasing LDL receptor activity to clear more cholesterol from the bloodstream.\n\nFenofibrate stimulates enzymes that enhance the oxidation of fatty acids and reduce triglyceride levels while increasing HDL.\n\nEzetimibe selectively inhibits the Niemann-Pick C1-Like 1 (NPC1L1) protein in the intestine, preventing dietary and biliary cholesterol absorption.\n\nTogether, these actions reduce LDL cholesterol, raise HDL, and lower triglycerides, offering complete lipid management.\n\nDirections for Use\nTake ATOVASTRIN EZ F exactly as prescribed by your physician.\n\nTypically, one tablet is taken once daily, preferably with or after a meal.\n\nSwallow the tablet whole with water — do not crush or chew.\n\nMaintain a low-fat, heart-healthy diet and follow regular exercise for best results.\n\nRegular monitoring of lipid profile, liver function, and renal function is advised during long-term use.\n\nDo not discontinue the medication without consulting your doctor.\n\nSide Effects\nLike all medications, ATOVASTRIN EZ F may cause some side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nHeadache\n\nMuscle pain or cramps\n\nDigestive disturbances (nausea, diarrhea, indigestion)\n\nFatigue\n\nMild elevation in liver enzymes\n\nRare but Serious Side Effects:\n\nRhabdomyolysis (muscle breakdown with dark urine and weakness)\n\nLiver toxicity\n\nPancreatitis\n\nGallstones (due to fenofibrate)\n\nAllergic reactions (rash, itching, swelling)\n\nSeek medical help immediately if you experience severe muscle pain, yellowing of eyes/skin, or signs of allergic reaction.", "price": 298.0, "discountamount": 90.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "allergic reaction", "dark urine", "renal function", "chew maintain", "meal swallow", "daily preferably", "physician typically", "fatty acids", "threepronged mechanism", "ldl hdl", "intestinal level", "comprehensive management", "triglyceride metabolism", "side effects", "atovastrin ez", "biliary cholesterol absorption", "cholesterol absorption inhibitor", "liver enzymes rare", "doctor side effects", "medications atovastrin ez", "work atovastrin ez", "reduce triglyceride levels", "results regular monitoring", "follow regular exercise", "lowfat hearthealthy diet", "intestine preventing dietary", "blood vessel health", "clearance simultaneously beneficial" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2100, "imageuri": "https://productimages.withfloats.com/actual/6815f505a654de67a62eb05a.png", "tileimageuri": "https://productimages.withfloats.com/tile/6815f505a654de67a62eb05a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-03T10:50:43.252Z", "updatedon": "2025-05-03T10:51:38.958Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/atovastrin-ez-f/2100", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Atrovastatin Calcium (10mg), Fenofibrate (160mg), Ezetimibe IP (10mg)", "category": "CARDIOLOGYRANGE", "tags": [ "Atorvastatin 10 mg and Fenofibrate 160 mg Tablet uses", "Atorvastatin 10 mg fenofibrate 160 mg side effects", "Atorvastatin 10 mg and Fenofibrate 160 mg brands", "Atorvastatin 10 Mg and Fenofibrate 160 mg Uses in Hindi", "Atorvastatin 10 mg and Fenofibrate 160 mg Price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666185c2161afa2274ff4d10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET GP 2 ", "description": "SEIZMET GP 2 \nGlimepiride (2mg), Metformin SR (500mg), Pioglitazone (15mg)\nIntroduction to SEIZMET GP 2\nSEIZMET GP 2 is a combination medication that includes Glimepiride 2mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Pioglitazone 15mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Pioglitazone, SEIZMET GP 2 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Pioglitazone?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that helps improve blood sugar control by increasing the body's sensitivity to insulin. It works by activating PPARγ (peroxisome proliferator-activated receptor gamma) receptors, which regulate the transcription of insulin-responsive genes involved in the control of glucose and lipid metabolism.\n\nBenefits of SEIZMET GP 2\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Pioglitazone enhances insulin sensitivity in peripheral tissues, providing a comprehensive approach to glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET GP 2 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET GP 2 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLipid Profile Improvement: Pioglitazone can improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, offering additional cardiovascular benefits.\nHow to Use SEIZMET GP 2\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET GP 2 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Pioglitazone. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET GP 2 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-gp-2-133443", "price": 145.5, "discountamount": 43.65, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "TZD", "body", "meal", "Diet", "Order", "EMAIL", "liver", "PPARγ", "water", "amount", "Action", "option", "Support", "pancreas", "Overview", "readings", "biguanide", "overweight", "one tablet", "Guidelines", "neuropathy", "full glass", "retinopathy", "utilization", "information", "Optimal Use", "Adjustments", "Introduction", "best results", "SEIZMET GP 2", "Pioglitazone", "Metformin SR", "sterisonline", "Reduced Risk", "Postprandial", "instructions", "sterispharma", "sulfonylurea", "triglycerides", "effectiveness", "CALL/WHATSAPP", "transcription", "Administration", "obese patients", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glimepiride 2mg", "lipid metabolism", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "weight neutrality", "thiazolidinedione", "excellent adjunct", "Weight Management", "insulin secretion", "peripheral tissues", "modest weight loss", "Recommended Dosage", "healthcare provider", "individual response", "blood sugar control", "insulin sensitivity", "Diabetes Management", "pancreatic beta cells", "HDL cholesterol levels", "combination medication", "cardiovascular disease", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "lifestyle modifications", "complementary mechanisms", "insulin-responsive genes", "type 2 diabetes mellitus", "Lipid Profile Improvement", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Hydrochloride Sustained Release", "peroxisome proliferator-activated receptor gamma) receptors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1443, "imageuri": "https://productimages.withfloats.com/actual/666185c5c06ee12d88cfaefd.png", "tileimageuri": "https://productimages.withfloats.com/tile/666185c5c06ee12d88cfaefd.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:47:46.414Z", "updatedon": "2024-06-29T09:07:17.281Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-gp-2-/1443", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET GP 2 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET GP 2", "Glimepiride (2mg)", "Metformin SR (500mg)", "Pioglitazone (15mg)", "Pioglitazone side effects", "Pioglitazone 15 mg price", "Side effects of pioglitazone 15 mg", "Is pioglitazone safe", "Pioglitazone uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66618121a743fd2358220c35", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "SEIZMET GP 1 ", "description": "SEIZMET GP 1 \nGlimepiride (1mg), Metformin SR (500mg), Pioglitazone (15mg)\nIntroduction to SEIZMET GP 1\nSEIZMET GP 1 is a combination medication that includes Glimepiride 1mg, Metformin Hydrochloride Sustained Release (SR) 500mg, and Pioglitazone 15mg. This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Glimepiride, Metformin, and Pioglitazone, SEIZMET GP 1 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Glimepiride, Metformin, and Pioglitazone?\nOverview of Glimepiride\nGlimepiride is a sulfonylurea that helps control blood sugar levels by stimulating the pancreas to release more insulin. It works by closing ATP-sensitive potassium channels in the pancreatic beta cells, leading to insulin secretion.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that helps improve blood sugar control by increasing the body's sensitivity to insulin. It works by activating PPARγ (peroxisome proliferator-activated receptor gamma) receptors, which regulate the transcription of insulin-responsive genes involved in the control of glucose and lipid metabolism.\n\nBenefits of SEIZMET GP 1\nEffective Blood Sugar Management\nTriple Mechanism of Action: Glimepiride stimulates insulin secretion, Metformin improves insulin sensitivity and reduces hepatic glucose production, and Pioglitazone enhances insulin sensitivity in peripheral tissues, providing a comprehensive approach to glycemic control.\nPostprandial and Fasting Glucose Control: This combination helps manage both postprandial (after-meal) and fasting blood sugar levels, offering all-around glycemic control.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: SEIZMET GP 1 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, SEIZMET GP 1 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nWeight Management: Metformin is often associated with weight neutrality or modest weight loss, making it a favorable option for overweight or obese patients.\nLipid Profile Improvement: Pioglitazone can improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, offering additional cardiovascular benefits.\nHow to Use SEIZMET GP 1\nDosage and Administration\nRecommended Dosage: The typical dosage of SEIZMET GP 1 is one tablet taken once or twice daily, depending on your healthcare provider's instructions. The dosage may be adjusted based on individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin and Pioglitazone. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take SEIZMET GP 1 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/seizmet-gp-1-133442", "price": 144.45, "discountamount": 43.34, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "TZD", "body", "Diet", "Order", "EMAIL", "liver", "PPARγ", "water", "meals", "amount", "Action", "option", "Support", "pancreas", "Overview", "readings", "biguanide", "neuropathy", "one tablet", "full glass", "Guidelines", "overweight", "Optimal Use", "information", "utilization", "Adjustments", "retinopathy", "Metformin SR", "SEIZMET GP 1", "best results", "Pioglitazone", "Introduction", "sterisonline", "Reduced Risk", "Postprandial", "instructions", "sterispharma", "sulfonylurea", "triglycerides", "effectiveness", "CALL/WHATSAPP", "transcription", "Administration", "obese patients", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glimepiride 1mg", "lipid metabolism", "Exercise Adjunct", "prolonged effect", "Triple Mechanism", "weight neutrality", "thiazolidinedione", "excellent adjunct", "Weight Management", "insulin secretion", "peripheral tissues", "modest weight loss", "Recommended Dosage", "healthcare provider", "individual response", "blood sugar control", "insulin sensitivity", "Diabetes Management", "pancreatic beta cells", "HDL cholesterol levels", "combination medication", "cardiovascular disease", "comprehensive approach", "Fasting Glucose Control", "long-term complications", "lifestyle modifications", "complementary mechanisms", "insulin-responsive genes", "type 2 diabetes mellitus", "Lipid Profile Improvement", "peripheral glucose uptake", "stable blood sugar levels", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "comprehensive glycemic control", "ATP-sensitive potassium channels", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Hydrochloride Sustained Release", "peroxisome proliferator-activated receptor gamma) receptors" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1440, "imageuri": "https://productimages.withfloats.com/actual/66618124c40ee9be019ac7b4.png", "tileimageuri": "https://productimages.withfloats.com/tile/66618124c40ee9be019ac7b4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T09:28:01.365Z", "updatedon": "2024-06-29T09:12:11.939Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/seizmet-gp-1-/1440", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET GP 1 ", "category": "DIABETIC RANGE", "tags": [ "SEIZMET GP 1", "Glimepiride (1mg)", "Metformin SR (500mg)", "Pioglitazone (15mg)", "Pioglitazone side effects", "Pioglitazone 15 mg price", "Pioglitazone uses", "Pioglitazone 30 mg uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66616218a743fd235822082f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS M 500 ", "description": "PIOSTERIS M 500 \nPioglitazone & Metformin Sustained Release Tablet\nIntroduction to PIOSTERIS M 500\nPIOSTERIS M 500 is a combination medication that includes Pioglitazone and Metformin Hydrochloride (Sustained Release). This medication is primarily used for the management of type 2 diabetes mellitus. By combining the complementary mechanisms of Pioglitazone and Metformin, PIOSTERIS M 500 offers comprehensive glycemic control, helping patients manage their blood sugar levels effectively.\n\nWhat are Pioglitazone and Metformin?\nOverview of Pioglitazone\nPioglitazone is a thiazolidinedione (TZD) that works by increasing the body's sensitivity to insulin. It helps lower blood sugar levels by making cells more responsive to insulin, enhancing glucose uptake in muscle and adipose tissue, and reducing hepatic glucose production.\n\nOverview of Metformin\nMetformin is a biguanide that helps lower blood sugar levels by improving the body's sensitivity to insulin and reducing the amount of glucose produced by the liver. It also enhances peripheral glucose uptake and utilization. The sustained-release formulation ensures a prolonged effect throughout the day.\n\nBenefits of PIOSTERIS M 500\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: Pioglitazone helps improve the body's response to insulin, while Metformin enhances insulin sensitivity and reduces hepatic glucose production.\nComprehensive Glycemic Control: The combination of these two medications provides a dual mechanism of action that targets multiple pathways of glucose regulation, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS M 500 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS M 500 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nSustained Blood Sugar Control: The sustained-release formulation of Metformin ensures prolonged blood sugar control throughout the day, improving patient compliance and overall effectiveness.\nHow to Use PIOSTERIS M 500\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS M 500 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to reduce the risk of gastrointestinal discomfort and enhance the effectiveness of Metformin. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS M 500 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-m-500-134243", "price": 118.0, "discountamount": 35.4, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "TZD", "day", "body", "Diet", "meals", "EMAIL", "cells", "water", "Order", "liver", "amount", "action", "muscle", "Support", "Overview", "readings", "patients", "biguanide", "one tablet", "full glass", "neuropathy", "Guidelines", "utilization", "retinopathy", "PIOSTERIS M", "Adjustments", "information", "Optimal Use", "Introduction", "best results", "Reduced Risk", "Pioglitazone", "sterisonline", "sterispharma", "CALL/WHATSAPP", "triglycerides", "Consistent Use", "treatment plan", "dual mechanism", "typical dosage", "adipose tissue", "lipid profiles", "Administration", "two medications", "Exercise Adjunct", "prolonged effect", "excellent adjunct", "multiple pathways", "thiazolidinedione", "glucose regulation", "Recommended Dosage", "patient compliance", "Insulin Sensitivity", "healthcare provider", "individual response", "Diabetes Management", "overall effectiveness", "HDL cholesterol levels", "cardiovascular disease", "combination medication", "Metformin Hydrochloride", "long-term complications", "lifestyle modifications", "complementary mechanisms", "type 2 diabetes mellitus", "Lipid Profile Improvement", "stable blood sugar levels", "peripheral glucose uptake", "hepatic glucose production", "Additional Health Benefits", "gastrointestinal discomfort", "sustained-release formulation", "prolonged blood sugar control", "Sustained Blood Sugar Control", "comprehensive glycemic control", "Effective Blood Sugar Management", "additional cardiovascular benefits", "Metformin Sustained Release Tablet", "comprehensive blood sugar management" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1411, "imageuri": "https://productimages.withfloats.com/actual/6661621b9a0a3c2c0600b4ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661621b9a0a3c2c0600b4ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:15:36.695Z", "updatedon": "2024-06-29T10:21:20.999Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//piosteris-m-500-/1411", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS M 500 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS M 500", "Pioglitazone", "Metformin Sustained Release Tablet", "Metformin hydrochloride 500 mg", "Metformin SR 500 dosage", "Metformin Hydrochloride Tablets IP 500mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6661614c870e7b20c49e4e49", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 7.5 ", "description": "PIOSTERIS 7.5 \nPioglitazone (7.5mg)\nIntroduction to PIOSTERIS 7.5\nPIOSTERIS 7.5 contains Pioglitazone 7.5mg, a medication used primarily for the management of type 2 diabetes mellitus. Pioglitazone belongs to a class of drugs known as thiazolidinediones (TZDs), which help improve blood sugar control by increasing the body's sensitivity to insulin. This medication is typically used in combination with diet and exercise to enhance glycemic control in adults with type 2 diabetes.\n\nWhat is Pioglitazone?\nOverview of Pioglitazone\nPioglitazone is an oral diabetes medication that works by making cells more sensitive to insulin, thereby allowing the body to use insulin more effectively. This helps lower blood sugar levels in patients with type 2 diabetes. Pioglitazone can be used alone or in combination with other antidiabetic medications.\n\nMechanism of Action\nInsulin Sensitization: Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which are involved in the regulation of genes responsible for glucose and lipid metabolism. This activation increases the sensitivity of body tissues to insulin.\nGlucose Uptake: By improving insulin sensitivity, Pioglitazone enhances glucose uptake in muscle and adipose tissue and reduces hepatic glucose production, leading to lower blood sugar levels.\nBenefits of PIOSTERIS 7.5\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: PIOSTERIS 7.5 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting insulin resistance, Pioglitazone provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS 7.5 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS 7.5 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nHow to Use PIOSTERIS 7.5\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS 7.5 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS 7.5 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-7-5-133430", "price": 59.0, "discountamount": 17.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "food", "TZDs", "diet", "lower", "cells", "class", "water", "drugs", "EMAIL", "Order", "genes", "adults", "muscle", "Action", "Support", "readings", "Overview", "patients", "same time", "PIOSTERIS", "one tablet", "full glass", "regulation", "activation", "neuropathy", "Guidelines", "retinopathy", "combination", "Consistency", "Adjustments", "information", "Optimal Use", "best results", "Reduced Risk", "sterispharma", "body tissues", "Pioglitazone", "Introduction", "sterisonline", "triglycerides", "CALL/WHATSAPP", "typical dosage", "Administration", "treatment plan", "Consistent Use", "lipid profiles", "adipose tissue", "Glucose Uptake", "Exercise Adjunct", "lipid metabolism", "unique mechanism", "PPARγ) receptors", "excellent adjunct", "insulin resistance", "thiazolidinediones", "Recommended Dosage", "insulin sensitivity", "Diabetes Management", "blood sugar control", "healthcare provider", "individual response", "Insulin Sensitization", "cardiovascular disease", "HDL cholesterol levels", "long-term complications", "lifestyle modifications", "oral diabetes medication", "type 2 diabetes mellitus", "Lipid Profile Improvement", "stable blood sugar levels", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "Comprehensive Glycemic Control", "other antidiabetic medications", "Effective Blood Sugar Management", "additional cardiovascular benefits", "comprehensive blood sugar management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1410, "imageuri": "https://productimages.withfloats.com/actual/6661614f7b1fc3f9dd4c82f7.png", "tileimageuri": "https://productimages.withfloats.com/tile/6661614f7b1fc3f9dd4c82f7.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:12:12.153Z", "updatedon": "2024-06-29T10:23:25.301Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/piosteris-7-5-/1410", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS 7.5 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS 7.5", "Pioglitazone (7.5mg)", "pioz 7.5 price", "pioz 7.5 side effects", "tab pioz 7.5 uses", "pioz 7.5 tablet 10" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66615f8cccd5ce1a10758f47", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 30 ", "description": "PIOSTERIS 30 \nPioglitazone (30mg)\nIntroduction to PIOSTERIS 30\nPIOSTERIS 30 contains Pioglitazone 30mg, a medication used primarily for the management of type 2 diabetes mellitus. Pioglitazone belongs to a class of drugs known as thiazolidinediones (TZDs), which help improve blood sugar control by increasing the body's sensitivity to insulin. This medication is typically used in combination with diet and exercise to enhance glycemic control in adults with type 2 diabetes.\n\nWhat is Pioglitazone?\nOverview of Pioglitazone\nPioglitazone is an oral diabetes medicine that works by making cells more sensitive to insulin, thereby allowing the body to use insulin more effectively. This helps lower blood sugar levels in patients with type 2 diabetes. Pioglitazone can be used alone or in combination with other antidiabetic medications.\n\nMechanism of Action\nInsulin Sensitization: Pioglitazone works by activating peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which are involved in the regulation of genes responsible for glucose and lipid metabolism. This activation increases the sensitivity of body tissues to insulin.\nGlucose Uptake: By improving insulin sensitivity, Pioglitazone enhances glucose uptake in muscle and adipose tissue and reduces hepatic glucose production, leading to lower blood sugar levels.\nBenefits of PIOSTERIS 30\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: PIOSTERIS 30 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting insulin resistance, Pioglitazone provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS 30 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS 30 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nHow to Use PIOSTERIS 30\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS 30 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS 30 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-30-134190", "price": 95.0, "discountamount": 28.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "TZDs", "diet", "food", "cells", "genes", "water", "Order", "class", "EMAIL", "drugs", "muscle", "adults", "Action", "Support", "readings", "Overview", "patients", "same time", "PIOSTERIS", "full glass", "Guidelines", "neuropathy", "one tablet", "activation", "regulation", "Optimal Use", "combination", "information", "Adjustments", "Consistency", "retinopathy", "sterisonline", "sterispharma", "best results", "Introduction", "Reduced Risk", "body tissues", "CALL/WHATSAPP", "triglycerides", "Administration", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glucose Uptake", "adipose tissue", "Exercise Adjunct", "PPARγ) receptors", "unique mechanism", "lipid metabolism", "excellent adjunct", "Pioglitazone 30mg", "insulin resistance", "thiazolidinediones", "Recommended Dosage", "insulin sensitivity", "healthcare provider", "Diabetes Management", "individual response", "blood sugar control", "Insulin Sensitization", "cardiovascular disease", "HDL cholesterol levels", "oral diabetes medicine", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "lower blood sugar levels", "stable blood sugar levels", "Lipid Profile Improvement", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "Comprehensive Glycemic Control", "other antidiabetic medications", "Effective Blood Sugar Management", "additional cardiovascular benefits", "comprehensive blood sugar management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1407, "imageuri": "https://productimages.withfloats.com/actual/66615f8f8e77bb2c715607af.png", "tileimageuri": "https://productimages.withfloats.com/tile/66615f8f8e77bb2c715607af.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T07:04:44.526Z", "updatedon": "2024-06-29T10:30:40.061Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//piosteris-30-/1407", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS 30 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS 30", "Pioglitazone (30mg)", "Pioglitazone 30mg uses", "Pioglitazone 30mg side effects", "Pioglitazone dose", "pioglitazone price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66615b6e161afa2274ff47c8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIOSTERIS 15 ", "description": "PIOSTERIS 15 \nPioglitazone (15mg)\nIntroduction to PIOSTERIS 15\nPIOSTERIS 15 contains Pioglitazone 15mg, a medication used primarily for the management of type 2 diabetes mellitus. Pioglitazone belongs to a class of drugs known as thiazolidinediones (TZDs), which help improve blood sugar control by increasing the body's sensitivity to insulin. This medication is typically used in combination with diet and exercise to enhance glycemic control in adults with type 2 diabetes.\n\nWhat is Pioglitazone?\nOverview of Pioglitazone\nPioglitazone is an oral diabetes medicine that works by making cells more sensitive to insulin, thereby allowing the body to use insulin more effectively. This helps lower blood sugar levels in patients with type 2 diabetes. Pioglitazone can be used alone or in combination with other antidiabetic medications.\n\nMechanism of Action\nInsulin Sensitization: Pioglitazone works by activating peroxisome proliferator-activated receptor gamma (PPARγ) receptors, which are involved in the regulation of genes responsible for glucose and lipid metabolism. This activation increases the sensitivity of body tissues to insulin.\nGlucose Uptake: By improving insulin sensitivity, Pioglitazone enhances glucose uptake in muscle and adipose tissue and reduces hepatic glucose production, leading to lower blood sugar levels.\nBenefits of PIOSTERIS 15\nEffective Blood Sugar Management\nImproved Insulin Sensitivity: PIOSTERIS 15 helps improve the body's response to insulin, leading to better control of blood sugar levels.\nComprehensive Glycemic Control: By targeting insulin resistance, Pioglitazone provides a unique mechanism of action that complements other diabetes medications, offering comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: PIOSTERIS 15 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, PIOSTERIS 15 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nLipid Profile Improvement: Pioglitazone has been shown to improve lipid profiles by lowering triglycerides and increasing HDL cholesterol levels, which can provide additional cardiovascular benefits.\nHow to Use PIOSTERIS 15\nDosage and Administration\nRecommended Dosage: The typical dosage of PIOSTERIS 15 is one tablet taken once daily. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with or without food. Swallow the tablet whole with a full glass of water. Consistency is key, so take the medication at the same time each day.\nGuidelines for Optimal Use\nConsistent Use: For best results, take PIOSTERIS 15 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/piosteris-15-133429", "price": 55.0, "discountamount": 16.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "TZDs", "diet", "food", "cells", "genes", "water", "Order", "class", "EMAIL", "drugs", "muscle", "adults", "Action", "Support", "readings", "Overview", "patients", "same time", "PIOSTERIS", "full glass", "Guidelines", "neuropathy", "one tablet", "activation", "regulation", "Optimal Use", "combination", "information", "Adjustments", "Consistency", "retinopathy", "sterisonline", "sterispharma", "best results", "Introduction", "Reduced Risk", "body tissues", "CALL/WHATSAPP", "triglycerides", "Administration", "typical dosage", "lipid profiles", "treatment plan", "Consistent Use", "Glucose Uptake", "adipose tissue", "Exercise Adjunct", "PPARγ) receptors", "unique mechanism", "lipid metabolism", "excellent adjunct", "Pioglitazone 15mg", "insulin resistance", "thiazolidinediones", "Recommended Dosage", "insulin sensitivity", "healthcare provider", "Diabetes Management", "individual response", "blood sugar control", "Insulin Sensitization", "cardiovascular disease", "HDL cholesterol levels", "oral diabetes medicine", "lifestyle modifications", "long-term complications", "type 2 diabetes mellitus", "lower blood sugar levels", "stable blood sugar levels", "Lipid Profile Improvement", "other diabetes medications", "Additional Health Benefits", "hepatic glucose production", "Comprehensive Glycemic Control", "other antidiabetic medications", "Effective Blood Sugar Management", "additional cardiovascular benefits", "comprehensive blood sugar management", "peroxisome proliferator-activated receptor gamma" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1406, "imageuri": "https://productimages.withfloats.com/actual/66615b718e77bb2c7155ff9e.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/66615b718e77bb2c7155ff9e.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T06:47:10.939Z", "updatedon": "2024-06-29T10:35:49.49Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/piosteris-15-/1406", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIOSTERIS 15 ", "category": "DIABETIC RANGE", "tags": [ "PIOSTERIS 15", "Pioglitazone (15mg)", "Pioglitazone 15 mg uses", "Pioglitazone side effects", "Pioglitazone dose", "Pioglitazone hydrochloride" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66556d31329f8d125c491c07", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROUSTRIN F 20", "description": "ROUSTRIN F 20\nRosuvastatin (20mg), Fenofibron (160mg)\n\"ROUSTRIN F 20: This medication effectively combines Rosuvastatin (20mg) and Fenofibrate (160mg) to manage cholesterol levels and reduce the risk of cardiovascular diseases. Rosuvastatin enhances lipid profiles by lowering bad cholesterol and triglycerides, while Fenofibrate helps in reducing fatty acids. Together, they provide a comprehensive solution for maintaining heart health. Always consult your doctor for personalized advice and dosage guidelines.\" For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\n", "price": 265.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "risk", "doctor", "medication", "Fenofibron", "ROUSTRIN F", "fatty acids", "Fenofibrate", "heart health", "Rosuvastatin", "triglycerides", "lipid profiles", "bad cholesterol", "dosage guidelines", "cholesterol levels", "personalized advice", "comprehensive solution", "cardiovascular diseases" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1203, "imageuri": "https://productimages.withfloats.com/actual/66556d40b2476ea84ea89068.png", "tileimageuri": "https://productimages.withfloats.com/tile/66556d40b2476ea84ea89068.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-05-28T05:35:45.127Z", "updatedon": "2024-06-11T10:20:33.587Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/roustrin-f-20/1203", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Rosuvastatin (20mg), Fenofibron (160mg)", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "683d992c87328f4e892f8716", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "EMPATECH 25", "description": "EMPATECH 25 is an advanced oral medication formulated with Empagliflozin 25 mg, a trusted and effective treatment for managing Type 2 Diabetes Mellitus (T2DM). It is part of a class of drugs known as SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors), designed to help lower blood sugar levels in adults when used alongside proper diet and exercise. EMPATECH 25 not only improves glycemic control but also contributes to weight management and cardiovascular health in diabetic patients.\n\nKey Ingredients\nEmpagliflozin 25 mg: A selective SGLT2 inhibitor that helps remove excess glucose from the body through urine, lowering blood sugar levels in patients with type 2 diabetes.\n\nKey Benefits\nHelps significantly reduce elevated blood glucose (HbA1c) levels in Type 2 Diabetes\n\nSupports weight loss by reducing excess sugar stored in the body\n\nAids in lowering systolic blood pressure\n\nDemonstrated cardiovascular benefits, including reduced risk of heart failure hospitalization\n\nEnhances overall glycemic control without causing hypoglycemia when used alone\n\nConvenient once-daily oral dosing\n\nHow Does It Work?\nEmpagliflozin blocks the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream.\n\nBy inhibiting this protein, the medication increases glucose excretion through urine, thereby lowering blood sugar levels.\n\nIt works independently of insulin, making it a suitable option even when insulin resistance is present.\n\nAdditionally, this mechanism reduces blood pressure and body weight, offering multiple metabolic benefits beyond blood sugar control.\n\nDirections for Use\nTake one tablet of EMPATECH 25 orally once a day, preferably at the same time each day.\n\nIt can be taken with or without food.\n\nFollow the dosage as prescribed by your healthcare provider.\n\nDo not crush, chew, or break the tablet; swallow it whole with water.\n\nMaintain regular blood sugar monitoring and adhere to a balanced diet and exercise regimen.\n\nSide Effects\nIncreased urination\n\nGenital infections (e.g., yeast infections)\n\nUrinary tract infections (UTIs)\n\nThirst and mild dehydration\n\nLow blood pressure (especially in people on diuretics)\n\nDizziness or lightheadedness\n\nPossible increase in cholesterol levels\n\nIn rare cases, ketoacidosis (seek immediate medical attention if symptoms like nausea, vomiting, or abdominal pain occur)", "price": 225.0, "discountamount": 68.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "tablet swallow", "day preferably", "body aids", "nausea vomiting", "medical attention", "cholesterol levels", "diuretics dizziness", "crush chew", "healthcare provider", "food follow", "empatech 25 orally", "present additionally", "insulin resistance", "suitable option", "insulin making", "works independently", "sglt2 protein", "causing hypoglycemia", "reduced risk", "cardiovascular health", "weight management", "exercise empatech 25", "effective treatment", "empatech 25empatech 25", "balanced diet", "empagliflozin 25 mg", "glycemic control", "improves glycemic control", "work empagliflozin blocks", "selective sglt2 inhibitor", "alongside proper diet", "abdominal pain occur", "reabsorbing glucose back" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2130, "imageuri": "https://productimages.withfloats.com/actual/683d99313e1ed3094cddca21.png", "tileimageuri": "https://productimages.withfloats.com/tile/683d99313e1ed3094cddca21.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-02T12:29:32.123Z", "updatedon": "2025-06-02T12:31:28.199Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empatech-25/2130", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Empagliflozin 25 mg", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 25 mg", "empagliflozin 25 mg tablet", "Empagliflozin 25 mg brands in India", "Empagliflozin 25 mg Price in India" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }